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ABSTRACT
Background Clinical guidelines advise GPs in England 
which patients warrant an urgent referral for suspected 
cancer. This study assessed how often GPs follow the 
guidelines, whether certain patients are less likely to be 
referred, and how many patients were diagnosed with 
cancer within 1 year of non- referral.
Methods We used linked primary care (Clinical 
Practice Research Datalink), secondary care (Hospital 
Episode Statistics) and cancer registration data. Patients 
presenting with haematuria, breast lump, dysphagia, 
iron- deficiency anaemia, post- menopausal or rectal 
bleeding for the first time during 2014–2015 were 
included (for ages where guidelines recommend urgent 
referral). Logistic regression was used to investigate 
whether receiving a referral was associated with feature 
type and patient characteristics. Cancer incidence (based 
on recorded diagnoses in cancer registry data within 
1 year of presentation) was compared between those 
receiving and those not receiving referrals.
Results 48 715 patients were included, of which 40% 
(n=19 670) received an urgent referral within 14 days of 
presentation, varying by feature from 17% (dysphagia) 
to 68% (breast lump). Young patients (18–24 vs 55–64 
years; adjusted OR 0.20, 95% CI 0.10 to 0.42, p<0.001) 
and those with comorbidities (4 vs 0 comorbidities; 
adjusted OR 0.87, 95% CI 0.80 to 0.94, p<0.001) were 
less likely to receive a referral. Associations between 
patient characteristics and referrals differed across 
features: among patients presenting with anaemia, 
breast lump or haematuria, those with multi- morbidity, 
and additionally for breast lump, more deprived patients 
were less likely to receive a referral. Of 29 045 patients 
not receiving a referral, 3.6% (1047) were diagnosed 
with cancer within 1 year, ranging from 2.8% for rectal 
bleeding to 9.5% for anaemia.
Conclusions Guideline recommendations for action are 
not followed for the majority of patients presenting with 
common possible cancer features. A significant number 
of these patients developed cancer within 1 year of their 
consultation, indicating scope for improvement in the 
diagnostic process.
INTRODUCTION
In 2015, the US Institute of Medicine 
report ‘Improving Diagnosis in Health 
Care’ highlighted the need to improve the 
quality and safety of diagnosis.1 It noted 
that ‘there are few clinical practice guide-
lines available for diagnosis’, contrasting 
this situation with the large number 
of guidelines aimed at improving the 
management of patients with a diagnosed 
illness. Guidelines for the management 
of patients with symptoms of possible 
cancer, which have been introduced in 
some health systems such as the English 
National Health Service (NHS), represent 
an important exception warranting inves-
tigation.2–4
The period between the patient’s first 
symptomatic presentation and cancer 
diagnosis is important, as shorter diag-
nostic intervals may contribute to an 
earlier stage at diagnosis and better 
patient experience.5–8 In order to improve 
the quality of diagnostic care and reduce 
delay, guidelines introduced in England 
in 2000 recommend that patients who 
present with certain features of possible 
cancer should be referred to hospital 
services by their GP for specialist assess-
ment within 2 weeks. Relevant ‘red- 
flag’ features for which urgent referrals 
are recommended were defined by the 
National Institute for Health and Care 
Excellence (NICE) initially in 20053 4 
and updated in 2015 mainly in order to 
lower the cancer risk threshold for inclu-
sion of features to 3%.9 The guidelines 
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include presenting features, which cover clinical signs 
such as breast lump, test results such as iron- deficiency 
anaemia, and symptoms such as haematuria.
Guidelines can only ever be as effective as the degree 
to which they are implemented. The implementation of 
the Two Week Wait guidelines has been associated with 
a continuous increase in the number of patients (with 
or without cancer) who are investigated expeditiously, 
and in improvements in care outcomes in patients with 
cancer.10–14 While this evidence indicates that the Two 
Week Wait guidelines are helping to improve diag-
nostic processes and outcomes in England, the extent 
to which they are adhered to is unknown. Other 
evidence suggests that there is some variation in the 
quality of diagnostic care in cancer patients initially 
presenting to primary care,15–18 the use of endoscopic 
investigations between GP practices, and the propor-
tion of cancer patients who were diagnosed after a 
Two Week Wait referral.16 19–21 Furthermore, previous 
observed inequalities in stage at diagnosis, referral 
interval and survival22–27 may suggest an association 
between certain patient characteristics (such as age, 
gender, socioeconomic status and ethnicity) and the 
risk of guideline non- adherence.
In principle, guideline- discordant referral behaviour 
may reflect accurate clinical judgement resulting in 
no adverse clinical outcomes for patients. How often 
this may be the case is, however, unknown, as studies 
thus far typically examined selected patients, such 
as from case series of malpractice claims including 
patients known to have been harmed.28–30 There is 
little evidence about the outcomes of non- adherence 
in population- based data. In this paper we focus on 
concordance with referral guidelines for patients 
presenting with features of possible cancer. Our 
research questions are:
1. To what extent are feature- based recommendations 
about referrals for suspected cancer included in NICE 
guidelines not followed?
2. Are patient factors associated with guideline discordant/
concordant care regarding referral decisions for suspect-
ed cancer?
3. What is the proportion of patients who were diagnosed 




The Clinical Practice Research Datalink (CPRD) is a 
large database of routinely collected UK primary care 
health records. In this study, we used CPRD GOLD 
data which covered approximately 7% of the UK 
population in 201431 and is collected from general 
practices using the Vision clinical software system. It 
contains clinical and administrative primary care data 
including diagnoses, investigations and treatments. A 
subset of CPRD GOLD practices subscribe to allow 
linkage of data to other sources. The CPRD data were 
linked at patient level to outpatient Hospital Episode 
Statistics (HES) data providing information on all 
referrals to NHS hospitals or NHS funded treatment 
centres, plus National Cancer Registration and Anal-
ysis Service (NCRAS) data providing information on 
cancer diagnoses, and patients’ Index of Multiple 
Deprivation (IMD—an area based measure of socio-
economic status based on the postcode of a patient’s 
residence).32 CPRD linked data have been used exten-
sively for cancer diagnostic studies.33–39 HES40 and 
NCRAS41–43 quality have been validated and CPRD 
maintain exacting standards regarding data quality and 
validation.44 45
Study population
We studied patients presenting to primary care during 
2014 and 2015 who presented with one of six features, 
as recorded in primary care notes: dysphagia, post- 
menopausal bleeding, iron- deficiency anaemia, rectal 
bleeding, haematuria, and female breast lump. For 
these presenting features NICE guidelines recommend 
urgent (i.e. Two Week Wait) referral for suspected 
cancer. Inclusion and exclusion criteria are shown in 
table 1. Age restrictions reflect those patients covered 
by the guidelines.
Patient and public involvement
A patient and public involvement group comprising 
five members met two times throughout the study 
period. The group was asked to reflect on the study 
design and research questions. Results, their meaning, 
and potential explanations were discussed at several 
stages. They contributed to identifying explanations 
for GP referral decision making and differences in 
referral level between patient groups.
Data analysis
The index consultation was defined for each patient 
as the first consultation with one of the six features. 
For these patients, referrals were identified in the 
HES dataset. Referral in HES is linked to the date the 
referral was received by the hospital, and recorded as 
‘Routine’, ‘Urgent’, ‘Two Week Wait’ or ‘Unknown’. 
As the NICE guidelines define an urgent referral as a 
referral to see a specialist within 2 weeks, an outcome 
of urgent referral was defined as a referral having 
been made in the 14 days after the index consulta-
tion with a recorded urgency of ‘Urgent’ or ‘Two 
Week Wait’. The choice for this definition was prag-
matic, acknowledging that there may be administra-
tive delays between a consultation occurring and a 
referral being made, and was supported by our data 
showing that most patients referred for an urgent 
assessment were referred within 2 weeks of the index 
consultation (online supplemental appendix A, figure 
A1). Existing feature code lists were used to identify 
presentations with features of interest. These code 
lists were developed using robust methods46 and have 
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been used successfully in previous studies.38 47 Patient 
age, gender, comorbidities, and previous cancer diag-
nosis were extracted from CPRD. Age was treated as a 
categorical variable with an 18- to 24- year- old group, 
10 year age groups between 25 and 84, and an 85 and 
older group. Comorbidities were conditions included 
in the Quality of Outcome Framework 2015/2016, 
using existing code lists applied to all CPRD data 
before a patient’s index consultation. A simple count 
of comorbidities was used, grouping those with four or 
more comorbidities together. National quintiles were 
used to define IMD groups.
After describing the proportion of patients receiving 
an urgent referral, we investigated which patient 
groups were more or less likely to receive an urgent 
referral using multilevel logistic regression. An initial 
main effects- only model included patient age, gender, 
deprivation level, number of comorbidities, feature 
type, previous history of cancer, and a random inter-
cept for referring clinician and general practice to 
account for clustering of patients within referring 
clinicians within practices. Between clinician and 
practice variation is quantified using the odds ratio 
covering the 95% mid- range of practices calculated 
from the estimated random effect variances.48 Refer-
ence categories were based on the highest number of 
patients with all genders and features represented. 
Interaction terms between patient characteristics and 
feature type were investigated individually with all 
significant interactions retained in the final model. We 
excluded 18 cases due to missing data on deprivation 
level. Significance of categorical variables was tested 
with a joint Wald test. The study power calculation 
assumed at least 8000 patients presenting with each 
feature, which would provide 90% power (p=0.05) 
to see a 4% absolute change from 25% discordant 
care in groups comprising 20% of the sample for any 
one feature (for example, 29% discordant care in the 
most deprived fifth of patients compared with 25% in 
others).
Finally, we investigated how many patients were 
diagnosed with cancer within 1 year of their index 
consultation by whether they received an urgent 
referral or not. Cancer incidence was based on the 
presence of a tumour in the NCRAS data with an 
International Classification of Diseases, 10th revision 
(ICD-10) invasive neoplasm code (C00 to C97 but 
excluding non- melanoma skin cancer, C44) and a date 
of diagnosis within 1 year of the index consultation.
Sensitivity analyses
We performed five sensitivity analyses. First, we 
repeated the analysis excluding urgent referrals and 
solely focusing on Two Week Wait ones, to assess 
whether including urgent referrals had an impact on 
the findings. Second, we examined the impact of our 
restriction that referrals must occur within 2 weeks of 
the index consultation by expanding this window to 90 
days. Third, the main analysis was repeated after also 
adjusting for ethnicity (extracted from HES; coded as 
white, black, Asian, mixed, and other ethnicity), which 
was not included in our main analysis due to a consider-
able amount of missing data (38%). Fourth, in addition 
to referrals captured in HES we also considered refer-
rals recorded in CPRD. Where a record of a referral 
flagged as ‘Two Week Wait’, ‘Red flag’ or ‘Urgent’ in 
either CPRD or HES was made within 2 weeks of first 
presentation, the patient was considered to have had 
an urgent referral. This sensitivity analysis allows for 
the possibility that GPs made referrals which were not 
recorded in HES (either because changes were made 
to the referral after it was made or because the referral 
was not captured by HES, for example, for an inves-
tigation outside of the outpatient setting). Fifth, a 




Registered at a CPRD GOLD 
practice that subscribes to data 
linkage
Patients who consulted 
with the same feature 
of interest as the index 
consultation in the 
year before the index 
consultation‡
A consultation with a medical 
code or test result (in the case 
of iron- deficiency anaemia) 
corresponding to a feature of 
interest during 2014 or 2015*
  







Rectal bleeding – 50
Haematuria – 45
Breast lump – 30
Continuous registration at the 
same general practice from a year 
before to a year after their first 
index consultation.‡
  
This table was created by the authors.
*There were minor changes in the recommendations for patients presenting with iron- 
deficiency anaemia and haematuria between the original (2005) and updated (2015) 
guidance. Therefore, we have restricted analysis to patients where an urgent referral 
would have been recommended in both sets of guidelines. Specifically for anaemia, 
inclusion as a first presentation was based on the more stringent test values included 
in the 2005 NICE guidelines of a haemoglobin level ≤11 g/dL for men and ≤10 g/
dL for women, plus a ferritin level <20 ng/mL and/or a mean red cell volume <80 
fL, and age restriction of 60 years and over related to the 2015 NICE guidelines. For 
haematuria, the 2015 NICE guidelines advise referral only if there is no evidence of a 
urinary tract infection, or if haematuria recurs or persists after successful treatment of 
a urinary tract infection. As such, the first and/or second consultation where antibiotics 
were prescribed in the absence of referral were excluded. Third visits within 6 months 
of the first visit were included regardless of GP treatment and referral decision- making.
†Although the guidelines do not specify an age range for post- menopausal bleeding, 
we exclude patients under the age of 45 years due to the small number in our sample 
(n=30).
‡With the exception of patients who presented with haematuria, the index 
consultation was defined for each patient as the first consultation with one or more 
of the six features based on medical codes for five features, and test results for iron- 
deficiency anaemia. For some patients presenting with haematuria, the second or third 
visit was included as their index consultation instead of the first visit, but exclusion 
criteria were applied to their first visit.
CPRD, Clinical Practice Research Datalink; GP, general practitioner; NICE, National 
Institute for Health and Care Excellence.
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sensitivity analysis was performed including neoplasm 
in situ (ICD-10 codes D00 to D48) in addition to inva-
sive neoplasms. All analyses were conducted using the 
statistical software Stata v14.2.49
RESULTS
Patient characteristics
There were 48 715 index consultations by patients 
with a feature of interest where a Two Week Wait 
referral would have been recommended (table 2). 
Among these patients, the most common presenting 
features were breast lump (33%) and rectal bleeding 
(27%). The mean age of the included patients was 60.4 
years (range 18–104; SD 15.6). However, age ranges 
varied by feature, with the lowest mean age of 49.5 
years (range 30–104 years; SD 13.7) for patients with 
breast lump and the highest mean age of 77.9 years for 
patients with anaemia (range 60–102; SD 9.1). Most 
patients had at least one comorbidity (80%). Patients 
who lived in an area classed as the lowest quintile (least 
deprived) of the IMD were over- represented (26% vs 
an expected 20%).
Urgent referrals
Overall, 40% (n=19 670) of patients received an 
urgent referral within 2 weeks of visiting the GP. 
The percentage of urgent referrals varied greatly by 
presenting feature, ranging from 17% (n=1384) 
for patients with dysphagia to 68% (n=11 007) for 
patients with breast lump (table 3).
Associations between patient characteristics and 
urgent referrals
The main effects- only models showed evidence that 
age (p<0.001), feature type (p<0.001), and comor-
bidities (p<0.001) were associated with the probability 
of receiving an urgent referral (online supplemental 
appendix A, figure A2; table 4). Patients with breast 
lump were most likely to receive a referral (adjusted OR 
compared with rectal bleeding: 16.85, 95% CI 15.56 
to 18.26). Younger age (adjusted OR 18–24 years vs 
55–64 years: 0.20, 95% CI 0.10 to 0.42) and greater 
number of comorbidities (adjusted OR 4 comorbidities 
vs 0 comorbidities: 0.87, 95% CI 0.80 to 0.94) were 
associated with a lower chance of receiving an urgent 














Total (n=48 715)N (%) N (%) N (%) N (%) N (%) N (%)
Age
  18 to 24 years – – 191 (2.3%) – – – 191 (0.4%)
  25 to 34 years – – 404 (4.9%) 1825 (11.3%) – – 2229 (4.6%)
  35 to 44 years – – 733 (8.9%) 4798 (29.8%) – – 5531 (11.4%)
  45 to 54 years – 2355 (18.0%) 1308 (16.0%) 5072 (31.5%) 1107 (17.0%) 1010 (28.6%) 10 852 (22.3%)
  55 to 64 years 103 (8.1%) 3815 (29.2%) 1521 (18.6%) 1883 (11.7%) 1305 (20.0%) 1463 (41.4%) 10 090 (20.7%)
  65 to 74 years 350 (27.6%) 3509 (26.9%) 1660 (20.3%) 1432 (8.9%) 1826 (28.0%) 658 (18.6%) 9435 (19.4%)
  75 to 84 years 481 (37.9%) 2468 (18.9%) 1513 (18.5%) 791 (4.9%) 1629 (25.0%) 313 (8.9%) 7195 (14.8%)
  85 or older 334 (26.3%) 920 (7.0%) 867 (10.6%) 317 (2.0%) 662 (10.1%) 92 (2.6%) 3192(6.6%)
Gender (female) 709 (55.9%) 6547 (50.1%) 4519 (55.1%) 16 118 (100%) 2223 (34.1%) 3536 (100%) 33 652 (69.1%)
IMD
  1 (least deprived) 249 (19.6) 3475 (26.6%) 1864 (22.7%) 4368 (27.1%) 1715 (26.3%) 1001 (28.3%) 12 672 (26.0%)
  2 276 (21.8%) 2996 (22.9%) 1727 (21.1%) 3491 (21.7%) 1548 (23.7%) 795 (22.5%) 10 833 (22.2%)
  3 277 (21.9%) 2733 (20.9%) 1786 (21.8%) 3284 (20.4%) 1390 (21.3%) 718 (20.3%) 10 188 (20.9%)
  4 272 (21.5%) 2193 (16.8%) 1524 (18.6%) 2737 (17.0%) 1086 (16.6%) 529 (15.0%) 8341 (17.1%)
  5 (most deprived) 192 (15.1%) 1664 (12.7%) 1294 (15.8%) 2232 (13.9%) 789 (12.1%) 492 (13.9%) 6663 (13.7%)
Ethnicity
  White 796 (62.8%) 6392 (48.9%) 3980 (48.6%) 10 535 (65.4%) 4130 (63.3%) 2249 (63.6%) 28 082 (57.7%)
  Black 13 (1.0%) 116 (0.9%) 54 (0.7%) 254 (1.6%) 58 (0.9%) 61 (1.7%) 556 (1.1%)
  Asian 31 (2.4%) 222 (1.7%) 182 (2.2%) 364 (2.3%) 93 (1.4%) 95 (2.7%) 987 (2.0%)
  Mixed 3 (0.2%) 28 (0.2%) 24 (0.3%) 112 (0.7%) 14 (0.2%) 12 (0.3%) 193 (0.4%)
  Other 12 (1.0%) 78 (0.6%) 58 (0.7%) 184 (1.1%) 38 (0.6%) 43 (1.2%) 413 (0.9%)
Comorbidities
  0 76 (6.0%) 2164 (16.6%) 1355 (16.5%) 4668 (29.0%) 927 (14.2%) 588 (16.6%) 9778 (20.1%)
  1 175 (13.8%) 2991 (22.9%) 1690 (20.6%) 4174 (25.9%) 1332 (20.4%) 923 (26.1%) 11 285 (23.2%)
  2 258 (20.4%) 2965 (22.7%) 1765 (21.5%) 3598 (22.3%) 1479 (22.7%) 808 (22.9%) 10 873 (22.3%)
  3 265 (20.9%) 2220 (17.0%) 1364 (16.6%) 2170 (13.5%) 1249 (19.1%) 629 (17.8%) 7897 (16.2%)
  ≥4 494 (39.0%) 2727 (20.9%) 2023 (24.7%) 1508 (9.4%) 1542 (23.6%) 588 (16.6%) 8882 (18.2%)
This table was created by the authors.
IMD, Index of Multiple Deprivation.
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referral (online supplemental appendix A, figure A2; 
table 4). There was substantial variation between 
both clinicians and practices, with the modelled OR 
covering the middle 95% of clinicians being 2.62, 
and practice being 1.62. The final model, including 
interactions between feature and patient factors, indi-
cated that the association between patient characteris-
tics and urgent referrals was highly dependent on the 
Table 3 Type of referrals given to patients within 2 weeks after visiting the GP with one or more of the six features
Features
Number of patients who did not 
receive an urgent referral
Number of patients who did 
receive an urgent referral
Referral types*
Two Week Wait 
referrals Urgent referrals
N (%) N (%) N (%)* N (%)*
Anaemia (n=1268) 1007 (79.4%) 261 (20.6%) 176 (13.9%) 85 (6.7%)
Rectal bleeding (n=13 067) 10 752 (82.3%) 2315 (17.7%) 1427 (10.9%) 888 (6.8%)
Dysphagia (n=8197) 6813 (83.1%) 1384 (16.9%) 990 (12.1%) 394 (4.8%)
Breast lump (n=16 118) 5111 (31.7%) 11 007 (68.3%) 8052 (50.0%) 2955 (18.3%)
Haematuria†(n=6529) 4043 (61.9%) 2486 (38.1%) 1479 (22.7%) 1007 (15.4%)
Post- menopausal bleeding (n=3536) 1319 (37.3%) 2217 (62.7%) 1598 (45.2%) 619 (17.5%)
Total (n=48 715) 29 045 (59.6%) 19 670 (40.4%) 13 722 (28.2%) 5948 (12.2%)
This table was created by the authors.
*Patients may have received several referral types within 2 weeks. The table describes whether patients received a Two Week Wait referral, and if not, whether they received an urgent 
referral.
†For haematuria, the number of referrals is based on referrals within 2 weeks after the first visit, referrals within 2 weeks after the second visit if patients received urinary tract infection 
treatment the first time, and referrals within 2 weeks after the third visit if patients received treatment during their first and second visit.
GP, general practitioner.
Table 4 Associations between patient characteristics and urgent referrals received within 2 weeks after visiting the GP (main analysis)
Unadjusted OR Lower 95% CI Upper 95% CI P value OR Lower 95% CI Upper 95% CI P value
Features
  Anaemia 1.17 1.01 1.37 <0.001 1.14 0.97 1.33 <0.001
  Rectal bleeding Ref Ref Ref Ref Ref Ref
  Dysphagia 0.91 0.84 0.99 1.01 0.93 1.09
  Breast lump 12.15 11.41 12.94 16.85 15.56 18.26
  Haematuria 3.29 3.05 3.54 3.29 3.05 3.54
  Post- menopausal bleeding 9.57 8.74 10.48 9.93 9.01 10.94
Age
  18 to 24 years 0.08 0.04 0.16 <0.001 0.20 0.10 0.42 <0.001
  25 to 34 years 1.41 1.28 1.56 0.37 0.33 0.41
  35 to 44 years 2.25 2.10 2.42 0.58 0.53 0.64
  45 to 54 years 1.47 1.39 1.56 0.80 0.75 0.86
  55 to 64 years Ref Ref Ref Ref Ref Ref
  65 to 74 years 0.90 0.84 0.96 1.11 1.04 1.20
  75 to 84 years 0.83 0.78 0.89 1.20 1.11 1.30
  85 or older 0.64 0.58 0.71 0.96 0.86 1.07
Sex (female) 3.06 2.92 3.21 <0.001 1.03 0.97 1.10 0.365
IMD             
  1 (least deprived) Ref Ref Ref 0.775 Ref Ref Ref 0.246
  2 0.98 0.93 1.05 1.01 0.94 1.09
  3 1.03 0.96 1.10 1.05 0.98 1.13
  4 1.00 0.93 1.08 1.09 1.01 1.18
  5 (most deprived) 1.00 0.92 1.08 1.06 0.97 1.17
Comorbidities
  0 Ref Ref Ref <0.001 Ref Ref Ref <0.001
  1 0.90 0.85 0.95 0.99 0.92 1.06
  2 0.85 0.80 0.90 0.97 0.91 1.04
  3 0.74 0.69 0.79 0.89 0.82 0.96
  ≥4 0.60 0.56 0.64 0.87 0.80 0.94
Previous history of cancer – – – 0.90 0.82 0.99 0.035
This table was created by the authors.
GP, general practitioner; IMD, Index of Multiple Deprivation.
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patient’s presenting features. Although there was no 
evidence for an average effect of deprivation across 
all features, there was evidence that patients living in 
more deprived neighbourhoods were more likely to be 
referred urgently if they presented with haematuria, 
post- menopausal bleeding, or rectal bleeding, though 
the opposite was true for women presenting with breast 
lump (online supplemental appendix A, figure A3(a)). 
Furthermore, patients presenting with anaemia, breast 
lump or haematuria were less likely to receive an 
urgent referral if they had a higher number of comor-
bidities, though the gradient was stronger in patients 
with anaemia than for other features (online supple-
mental appendix A, figure A3(b)). Finally, although 
the association between age and urgent referral was 
similar for all patients, the size of age variation was 
greater for patients presenting with dysphagia and 
breast lump (online supplemental appendix A, figure 
A3(c)). However, this largely reflected the larger age 
range covered by referral guidelines for those features. 
Sensitivity analyses excluding the 58% of patients 
who received an urgent as opposed to Two Week Wait 
referral (online supplemental appendix A, table A1), 
or including ethnicity (online supplemental appendix 
A, table A2), showed similar results. The sensitivity 
analysis for urgent referrals occurring within 90 days 
of presentation showed that 44% (as opposed to 40% 
in the main analysis) of patients received a referral, 
and showed similar variation by age, feature type 
and number of comorbidities to the main analysis 
(online supplemental appendix A, table A3). Finally, 
the sensitivity analysis including urgent referrals 
recorded in either HES or CPRD within 2 weeks of the 
index consultation identified a further 3503 patients 
receiving a referral, indicating that 48% of patients 
received an urgent referral (online supplemental 
appendix A, table A4).
Cancer diagnoses
Of the 19 670 patients who received an urgent referral, 
1950 (9.9%) went on to be diagnosed with cancer 
within 1 year. Of the 29 045 patients who did not 
receive an urgent referral, 1047 (3.6%) patients were 
diagnosed with cancer within 1 year. As a result, 35% 
of all patients diagnosed with cancer in the year after 
consulting their GP with one of the six features had 
not received a recorded urgent referral within 2 weeks 
of their index consultation (online supplemental 
appendix A, table A5). The percentage of patients diag-
nosed with cancer without having received a referral 
varied between features, from 2.8% for rectal bleeding 
to 9.5% for patients with iron- deficiency anaemia 
(table 5; Online supplemental appendix A, figure A4). 
The sensitivity analysis, which included urgent refer-
rals captured by either CPRD or HES, found that 
3.2% of patients who did not receive a referral were 
diagnosed with cancer within 1 year of their index 
consultation (online supplemental appendix A, table 
A6). The sensitivity analysis, including both invasive 
neoplasms and neoplasms in situ, showed similar 
results with 4.2% of patients diagnosed with either 
type of neoplasm within 1 year (compared with 3.6% 
for invasive neoplasms and HES recorded referrals 
alone) (online supplemental appendix A, table A7). 
The percentage of patients diagnosed with cancer of 
a specific site within 1 year of not receiving an urgent 
referral was low for most cancers (table 5), with the 
exceptions of colorectal cancer for patients with iron- 
deficiency anaemia (5.5%), breast cancer for patients 
with breast lump (3.5%), and uterine cancer for 
patients with post- menopausal bleeding (2.9%).
DISCUSSION
Statement of principal findings
Six out of 10 patients presenting to primary care 
with a high- risk feature of possible cancer did not 
receive an urgent referral in the 14 days after pres-
entation, despite this being a guideline- recommended 
action. Urgent referral frequency varied by feature, 
with patients with breast lump receiving the highest 
percentage of referrals and patients with dysphagia the 
lowest. Younger patients, and those with comorbidities 
were less likely to receive an urgent referral. Associa-
tions between patient characteristics and urgent refer-
rals differed by feature. More deprived women with 
breast lump, and patients with anaemia, breast lump, 
or haematuria and multi- morbidity were less likely to 
receive a referral; 3.6% of patients who did not receive 
an urgent referral were diagnosed with cancer within 
1 year, this percentage varying between 2.8% for rectal 
bleeding and 9.5% for iron- deficiency anaemia.
Strengths and limitations
We used a large, longitudinal, validated linked dataset 
which has been used extensively for cancer diag-
nostic studies,10 50 51 enabling important insights into 
patients’ journeys through the healthcare system. 
However, there are limitations. First, as an urgently 
referred patient would usually be investigated in an 
outpatient setting, the HES dataset comprised outpa-
tient hospital data. Consequently, patients referred 
and admitted to hospital or directed to an emergency 
department will not have been identified even though 
timely action was taken. However, the number of 
such patients is likely small for the studied presenting 
features, especially given the substantial decrease in 
the number of cancers diagnosed following emergency 
GP referrals in the last decade.13 Second, identifica-
tion of index consultations with one of the six features 
was based on medical codes in patient records. Some 
patients may have been missed because the feature was 
only recorded in inaccessible ‘free text’ (which is not 
available to researchers to avoid de- anonymisation) or 
because the feature was not recorded at all. However, 
CPRD studies of free- text data suggest it usually only 
confirms coded entries.52 Consequently, some patients 
copyright.
 on O











af: first published as 10.1136/bm





7Wiering B, et al. BMJ Qual Saf 2021;0:1–11. doi:10.1136/bmjqs-2021-013425
Original research
Table 5 Main cancer diagnoses within 1 year of the index GP visit
Features
  
Main cancer types for patients who did not receive 
an urgent referral










Anaemia 1 Colorectal cancer 55 5.5% Colorectal cancer 44 16.9%
2 Oesophagogastric cancer 12 1.2% Oesophagogastric cancer 5 1.9%
3 Breast cancer 7 0.7% Prostate cancer 3 1.1%
Total number of diagnoses† 98 9.7% Total number of diagnoses† 64 24.5%
Total number of patients 
diagnosed with cancer





1 Colorectal cancer 159 1.5% Colorectal cancer 148 6.4%
2 Prostate cancer 41 0.4% Breast cancer 11 0.5%
3 Breast cancer 21 0.2% Anal cancer 10 0.4%
Total number of diagnoses† 316 2.9% Total number of diagnoses† 205 8.9%
Total number of patients 
diagnosed with cancer
299 2.8% Total number of patients 
diagnosed with cancer
200 8.6%
Dysphagia 1 Oesophagogastric cancer 108 1.6% Oesophagogastric cancer 53 3.8%
2 Breast cancer 19 0.3% Lip, oral cavity and pharynx 
cancer
10 0.7%
3 Lung cancer 14 0.2% Lung cancer 7 0.5%
Total number of diagnoses† 212 3.1% Total number of diagnoses† 89 6.4%
Total number of patients 
diagnosed with cancer





1 Breast cancer 179 3.5% Breast cancer 1138 10.3%
2 Melanoma 4 0.1% Colorectal cancer 9 0.1%
3 Colorectal cancer 2 0.0% Lung cancer 6 0.1%
Total number of 
diagnoses†
194 3.8% Total number of 
diagnoses†
1184 10.8%
Total number of 
patients diagnosed 
with cancer




Haematuria 1 Bladder cancer 66 1.6% Bladder cancer 139 5.6%
2 Prostate cancer 54 1.3% Prostate cancer 54 2.2%
3 Kidney cancer 24 0.6% Kidney cancer 40 1.6%
Total number of 
diagnoses†
209 5.2% Total number of 
diagnoses†
289 11.6%
Total number of 
patients diagnosed 
with cancer




Post- menopausal bleeding 1 Uterine cancer 38 2.9% Uterine cancer 134 6.0%
2 Breast cancer
 
5 0.4% Ovarian cancer 11 0.5%
3 Ovarian cancer 2 0.2% Breast cancer 9 0.4%
Total number of 
diagnoses†
53 4.0% Total number of 
diagnoses†
179 8.1%
Total number of 
patients diagnosed 
with cancer




This table was created by the authors.
*Percentage of cancer diagnoses compared with the number of patients who received or did not receive an urgent referral.
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with features of interest may not have been included in 
the study. However, those who were included almost 
certainly had the feature, and thus a Two Week Wait 
referral would have been recommended. Third, inclu-
sion of patients was limited to 2014 and 2015 as cancer 
registry data were only available up to and including 
2016 at the time of data extraction. However, it 
is unlikely that this will have affected results, as the 
guidelines had been in use for a number of years, and 
analyses were restricted to patients where an urgent 
referral would have been recommended in both the 
2005 and 2015 guidance. Fourth, we excluded patients 
with haematuria who were treated for possible urinary 
tract infection (unless it was not the last visit or a 
third consultation within 6 months) on the basis of 
prescriptions for two of the most common first- line 
antibiotics for urinary tract infection. A small number 
of patients will have been prescribed different antibi-
otics and been included in error. Fifth, although the 
study showed that many patients were diagnosed 
with cancer after not receiving an urgent referral 
after presenting with a suspected cancer feature, we 
were unable to give insight into the potential impact 
of non- referral on cancer stage. Finally, we note that 
although for three features we exceeded our planned 
sample size, the number of patients presenting with 
iron- deficiency anaemia or post- menopausal bleeding 
was significantly less than planned.
Comparison with existing evidence and meaning of 
the study
Previous studies have reported that the number of 
GP consultations before referral varied by cancer 
type.53 It appears that GPs are less likely to suspect 
cancer for some features compared with others. This 
may be partially explained by the greater likelihood 
of some features being caused by other explanations 
than cancer. However, the risk of cancer with all 
these features is always low in absolute terms, with 
iron- deficiency anaemia having the highest positive 
predictive value of the six for cancer (for men over 
60 years with a haemoglobin <11 g/dL and features of 
iron deficiency, the positive predictive value is 13%54). 
The decision to refer may be influenced by factors 
other than guidelines, such as GPs’ symptom inter-
pretation,55 additional presenting features supporting 
a different diagnosis, and clinical intuition,56 but also 
by how local health services are organised.20 Varia-
tion in referral has been shown to be partly attribut-
able to Clinical Commissioning Groups (CCGs) and 
Acute Hospital Trusts.20 This is supported by qualita-
tive research suggesting that GPs are hesitant to refer 
or even feel pressured by CCGs to not refer due to 
resource pressures.57 Additionally, although prob-
ably only responsible for a small proportion of non- 
referrals, there are a number of other factors which 
may affect whether a referral was made or recorded 
(box 1). Regardless of the GPs’ reasons for referral or 
non- referral, our study shows that GPs often made 
the right decision regarding referral for their patients. 
Given the proportion of patients going on to be diag-
nosed with cancer was considerably higher in those 
receiving an urgent referral than those who did not, 
we can conclude that GP referral decision- making 
is not without value. However, given the number of 
patients diagnosed with cancer after non- referral, 
we may question whether clinical judgement is good 
enough: 5.5% of patients with anaemia not receiving 
an urgent referral were diagnosed with colorectal 
cancer within 1 year, 3.5% of women presenting with 
breast lump who did not receive a referral were diag-
nosed with breast cancer, and 2.9% who presented 
with post- menopausal bleeding were diagnosed with 
uterine cancer. In these patients it can be argued 
that guideline- discordant decision- making may have 
resulted in a missed opportunity to diagnose early. 
Better adherence to the guidelines may therefore be 
important in order to increase detection rate, even for 
alarm features with already high urgent referral rates.
Our finding that younger patients were less likely 
to receive an urgent referral reflects earlier research 
reporting that younger patients typically experi-
ence longer diagnostic timelines.53 The present study 
also offers new insights into how multi- morbidity 
may affect diagnostic timeliness. Although there are 
suggestions that more contact with health services 
can shorten diagnostic intervals, a growing body 
of evidence suggests that multi- morbidity can also 
prolong diagnostic intervals.15 58–61 Given our findings, 
Box 1 
Mechanisms affecting referral
Although we expect that it only affects a small number of 
patients, there are a number of mechanisms besides GP 
referral decision- making which may potentially influence 
whether an urgent referral was made or recorded:
 ► Patients were admitted to hospital via emergency 
admission
 ► The referral was not accepted by the hospital. (This 
should be captured by the sensitivity analysis including 
Clinical Practice Research Datalink (CPRD) referrals)
 ► The patient refused to be referred
 ► A downgrade of the urgency level of the referral 
was requested by the hospital. (This should still be 
captured in the CPRD sensitivity analysis)
 ► Index consultation took place with out- of- hours 
practice services
 ► Variations in local guidelines for referral. (For most 
patients this should be captured in either the 
sensitivity analysis including CPRD referrals or the 
sensitivity analysis including referrals made up to 90 
days after presentation)
 ► The patient received a related referral before first 
presentation, which affected the decision to refer
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it may be these prolonged intervals arise, in part, due 
to a lower likelihood of receiving an urgent referral. 
Additionally, research suggests that multi- morbidity is 
associated with decreased use of specialist investiga-
tions.62 This may explain the strong multi- morbidity 
gradient observed for patients with anaemia where 
urgent referral would lead to an invasive test. Future 
research investigating how multi- morbidity affects GP 
referral decision- making for potential cancer features 
may help target improvement efforts.
Although, on average, deprivation was not associ-
ated with urgent referrals, more deprived patients 
with haematuria, rectal or post- menopausal bleeding 
were more likely to receive a referral. Although we 
can only speculate, this finding could be explained 
by earlier research suggesting that deprived patients 
are more likely to delay presentation,63 64 resulting in 
more serious potential cancer features, increasing the 
chance of an urgent referral. On the other hand, more 
deprived women presenting with breast lump were less 
likely to receive an urgent referral. As few women with 
breast cancer delay presentation,63 the association 
between deprivation and referral is likely to reflect 
differences post- presentation. Patients with a higher 
socioeconomic status tend to be more effectively able 
to communicate their symptoms and concerns,65 66 
while GPs’ communication tends to be more patient- 
centred with less deprived patients.67 This may poten-
tially result in closer alignment in perceptions of 
symptom significance68 and influence GPs’ decision to 
refer.
We have identified patient groups who may be at 
risk of longer diagnostic timelines. GPs may be less 
likely to refer patients when their age,69 or alternative 
medical explanations, suggest a lower risk of cancer. 
However, guidelines incorporate patient age and thus 
recommended action is still appropriate for those age 
groups.
Clinical practice guidelines have been shown to 
improve treatment quality for a range of conditions 
and could also help to improve the quality of the 
diagnostic process. However, our study shows that 
recommendations for the assessment of patients with 
features of possible cancer are not always followed. 
Stricter adherence to the guidelines and increased 
awareness of patient groups especially at risk of long 
diagnostic timelines may help improve early diagnosis 
and ultimately cancer survival rates. Due to the poten-
tial impact of regional health services, interventions to 
reduce guideline discordant behaviour may have more 
impact if they do not just focus on GPs and individual 
practices, but also on local diagnostic service provision.
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